-transparent.png){kind=logo}
Sialidosis, a lysosomal storage disease, ranged as oligosaccharidosis, is a genetic enzyme defect with a significantly restricted survival rate of the child concerned. After the preceded birth of a child who died of sialidosis, we succeeded in the correct prenatal exclusion of the disease with the prediction of a heterocygotic carrier status by biochemical analysis of cultivated amnion cells. The growth of these cells as well as the postnatal examined fibroblasts was significantly reduced. The possibility of the prenatal diagnosis of sialidosis allowed a pregnancy following the birth of a diseased child.
Related Publications
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
July 1979,
Clinical genetics,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
July 1993,
Clinical genetics,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
January 1980,
Advances in experimental medicine and biology,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
July 2001,
FEBS letters,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
December 1996,
Genes & development,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
January 1979,
American journal of human genetics,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
February 1983,
Clinical genetics,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
November 2000,
Human molecular genetics,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
August 1982,
Clinica chimica acta; international journal of clinical chemistry,
H Heyes, and
J Gehler, and
U Töllner, and
E Göltner
May 1982,
Journal of the neurological sciences,
